MTOR and breast cancer: Indeed, the PI3K/Akt/mTOR pathway is the most commonly upregulated pathway in HR- and HER2+ breast cancers, being involved in many aspects of cell growth, proliferation, survival, metabolism, and immune response regulation [40].